Axent Biosciences
PrivateLast Round
Seed
Sep 20, 2024
Total Funding Raised
$10.1M
Company Overview
Axent Biosciences is a biotechnology company developing next-generation cell therapies using engineered biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axent Biosciences Comparables
Compare Axent Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TreeFrog Therapeutics | 77% | |
| Syntax Bio | 76% | |
| Cellino | 76% |
Axent Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 20, 2024 | ||||
| Grant | Jul 17, 2024 | ||||
| Accelerator | Aug 18, 2020 |
Axent Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Berkeley SkyDeck | Seed, Accelerator |
| California Institute for Regenerative Medicine | Grant |
| Berkeley Frontier Fund | Seed |
| Kerna Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 20, 2024
$6M raised from Berkeley Frontier Fund and Kerna Ventures.
- Sep 18, 2024
Grew 25% QoQ, from 12 to 15 employees.
Axent Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Axent Biosciences's valuation, stock price, and market status.
Is Axent Biosciences a public or private company?
Axent Biosciences is a private company.
What is the current stock price of Axent Biosciences?
Axent Biosciences is a private company, so its shares have no public market price. Caplight tracks Axent Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axent Biosciences worth (valuation)?
Valuation information for Axent Biosciences is not publicly available.
Can I buy Axent Biosciences stock?
Axent Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axent Biosciences's last funding round?
Axent Biosciences's most recent funding round was Seed on September 20, 2024.
Who are the main investors in Axent Biosciences?
Key investors in Axent Biosciences include Berkeley SkyDeck, California Institute for Regenerative Medicine, Berkeley Frontier Fund, Kerna Ventures.
Will Axent Biosciences IPO soon?
No public IPO plans have been announced for Axent Biosciences.
How can I track Axent Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Axent Biosciences's shares on secondary markets.